Cargando…
EZH2 inhibition promotes tumor immunogenicity in lung squamous cell carcinomas
Two important factors that contribute to resistance to immune checkpoint inhibitors (ICIs) are an immune-suppressive microenvironment and limited antigen presentation by tumor cells. In this study, we examine if inhibition of the methyltransferase EZH2 can increase ICI response in lung squamous cell...
Autores principales: | DuCote, Tanner J., Song, Xiulong, Naughton, Kassandra J., Chen, Fan, Plaugher, Daniel R., Childress, Avery R., Edgin, Abigail R., Qu, Xufeng, Liu, Jinze, Liu, Jinpeng, Li, Fei, Wong, Kwok-Kin, Brainson, Christine F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10274685/ https://www.ncbi.nlm.nih.gov/pubmed/37333199 http://dx.doi.org/10.1101/2023.06.06.543919 |
Ejemplares similares
-
Dysregulated Polycomb Repressive Complex 2 contributes to chronic obstructive pulmonary disease by rewiring stem cell fate
por: Byrd, Aria L., et al.
Publicado: (2022) -
Cellular Origins of EGFR‐Driven Lung Cancer Cells Determine Sensitivity to Therapy
por: Chen, Fan, et al.
Publicado: (2021) -
Polycomb deficiency drives a FOXP2-high aggressive state targetable by epigenetic inhibitors
por: Chen, Fan, et al.
Publicado: (2023) -
Burkholderia multivorans requires species‐specific GltJK for entry of a contact‐dependent growth inhibition system protein
por: Myers‐Morales, Tanya, et al.
Publicado: (2021) -
Immunogenicity of recurrent mutations in MYD88 and EZH2 in non-Hodgkin lymphomas
por: Nielsen, Julie S, et al.
Publicado: (2015)